The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

MDS 2020 | MDS pathology and comorbidities

Name: MDS pathology and comorbidities
Uploaded: 2020-03-05T00:00:00.000Z
Duration: 1 min 59 s
Description: Theo de Witte, MD, Radboud University Medical Center, Nijmegen, The Netherlands, discusses the pathology of myelodysplastic syndromes (MDS) and how our understanding has expanded since the molecular era. The issue of comorbidities in MDS patients is also outlined. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Theo de Witte • 5 Mar 2020

MDS 2020

Myelodysplastic Syndromes

Theo de Witte, MD, Radboud University Medical Center, Nijmegen, The Netherlands, discusses the pathology of myelodysplastic syndromes (MDS) and how our understanding has expanded since the molecular era. The issue of comorbidities in MDS patients is also outlined. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.